US2023022324A1PendingUtilityA1

Compositions and methods to regulate hormonal cascades in stress disorders

Assignee: BIOMMUNITY INCPriority: May 30, 2017Filed: May 23, 2022Published: Jan 26, 2023
Est. expiryMay 30, 2037(~10.9 yrs left)· nominal 20-yr term from priority
Inventors:Paul G. Emerson
A61K 31/353A61P 25/02A61P 25/28A61K 31/381A61K 31/198A61P 25/30A61P 5/00A61P 25/00A61P 9/12A61K 31/137A61K 45/06A61K 36/48A61K 31/385A61K 31/352
66
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention is composition and methods that restore balance to the stress-related steroidal hormone cascade. Upon co-administration, the compounds of the invention restore balance to the cascade and promote or restore normal function in patients suffering from a disorder having a primary psychological stress component. The compositions include a selected combination of isoflavones, alpha lipoic acid, and L dopamine or a precursor thereof, and are preferably obtained from the natural sources disclosed herein. The uses of the invention include administration of the disclosed compositions to patients suffering from PTSD, fibromyalgia, endometriosis, and other disorders having a common chronic stress component.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A composition comprising a physiologically active dose of:
 (1) an R(+) enantiomer of alpha lipoic acid;   (2) a naturally occurring substance containing a dopamine precursor; and   (3) a plurality of isoflavones having the formula:   
       
         
           
           
               
               
           
         
         and combinations thereof wherein the plurality of the isoflavones where R1=H and R2=CH3 and R1=OH and R2=CH3 are at least 30% of a total isoflavone dosage and are present in a ratio between 1:2 and 2:1.

Join the waitlist — get patent alerts

Track US2023022324A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.